Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2025-12-25 @ 8:49 PM
Study NCT ID:
NCT01482169
Status:
COMPLETED
Last Update Posted:
2018-05-11
First Post:
2011-11-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)
Sponsor:
Ochsner Health System
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03
Start Date Type:
None
Primary Completion Date:
2014-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-15
First Submit QC Date:
None
Study First Post Date:
2011-11-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-26
Results First Submit QC Date:
None
Results First Post Date:
2018-05-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-09
Last Update Post Date:
2018-05-11
Last Update Post Date Type:
ACTUAL